BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8467500)

  • 1. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
    Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
    Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid growth suppression response in 13762NF adenocarcinoma-derived Con8 rat mammary tumor cells is mediated by dominant trans-acting factors.
    Webster MK; Guthrie J; Firestone GL
    Cancer Res; 1991 Nov; 51(22):6031-8. PubMed ID: 1933866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
    Goya L; Maiyar AC; Ge Y; Firestone GL
    Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells.
    Buse P; Woo PL; Alexander DB; Cha HH; Reza A; Sirota ND; Firestone GL
    J Biol Chem; 1995 Mar; 270(12):6505-14. PubMed ID: 7896785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of rat mammary tumor cell growth in vitro by glucocorticoids requires serum proteins. Characterization of wild type and glucocorticoid-resistant epithelial tumor cells.
    Webster MK; Guthrie J; Firestone GL
    J Biol Chem; 1990 Mar; 265(9):4831-8. PubMed ID: 2318865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
    Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional glucocorticoid receptor modulates pancreatic carcinoma growth through an autocrine loop.
    Norman J; Franz M; Schiro R; Nicosia S; Docs J; Fabri PJ; Gower WR
    J Surg Res; 1994 Jul; 57(1):33-8. PubMed ID: 7518883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.
    Meisler N; Shull S; Xie R; Long GL; Absher M; Connolly JP; Cutroneo KR
    J Cell Biochem; 1995 Nov; 59(3):376-88. PubMed ID: 8567755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta production and induction of cellular responses in 13762NF rat mammary adenocarcinoma cell clones.
    Kaufmann AM; Stoeck M; Schirrmacher V; Lichtner RB
    Invasion Metastasis; 1993; 13(5):244-52. PubMed ID: 7960577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of recombinant retroviral vector expressing antisense TGF alpha on malignant phenotype of human pancreatic carcinoma cell line.
    Xu Y; Liu T; Gao J
    Chin Med J (Engl); 1998 Apr; 111(4):334-8. PubMed ID: 10374398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-alpha abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway.
    Guan Y; Woo PL; Rubenstein NM; Firestone GL
    Exp Cell Res; 2002 Feb; 273(1):1-11. PubMed ID: 11795941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
    Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
    Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
    Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.